Cargando…

Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study

Neuropsychiatric symptoms have been reported in patients receiving dolutegravir, a known inhibitor of the renal and neuronal-expressed organic anion transporter 2 (encoded by SLC22A2 gene). The effect of the genetic variant SLC22A2 808C>A on dolutegravir discontinuation was assessed and analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cusato, Jessica, Borghetti, Alberto, Teti, Elisabetta, Milesi, Maurizio, Tettoni, Maria Cristina, Bonora, Stefano, Trunfio, Mattia, D’Avolio, Antonio, Compagno, Mirko, Di Giambenedetto, Simona, Di Perri, Giovanni, Calcagno, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781993/ https://www.ncbi.nlm.nih.gov/pubmed/36557240 http://dx.doi.org/10.3390/metabo12121202

Ejemplares similares

A filter-based cross-sectional analysis of an HIV-positive, HAART-treated cohort in rural Burundi: pharmacokinetics, pharmacogenetics and viral load
por: Calcagno, A, et al.
Publicado: (2010)

Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants
por: Cusato, Jessica, et al.
Publicado: (2023)

Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

Blood–Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers
por: Caligaris, Giulia, et al.
Publicado: (2021)

Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options
por: Trunfio, Mattia, et al.
Publicado: (2022)

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy
por: Calcagno, Andrea, et al.
Publicado: (2021)

Analysis of determinants of long-term efficacy of unboosted atazanavir-based regimens in the clinical setting
por: Bonora, S, et al.
Publicado: (2010)

A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
por: Baietto, Lorena, et al.
Publicado: (2014)

The Effect of Rifampicin on Darunavir, Ritonavir, and Dolutegravir Exposure within Peripheral Blood Mononuclear Cells: a Dose Escalation Study
por: De Nicolò, Amedeo, et al.
Publicado: (2022)

Analytical Validation and Clinical Application of Rapid Serological Tests for SARS-CoV-2 Suitable for Large-Scale Screening
por: De Nicolò, Amedeo, et al.
Publicado: (2021)

Co-infection with other respiratory pathogens in COVID-19 patients
por: Calcagno, Andrea, et al.
Publicado: (2021)

Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers
por: Trunfio, Mattia, et al.
Publicado: (2021)

COVID-19: A Possible Contribution of the MAPK Pathway
por: Cusato, Jessica, et al.
Publicado: (2023)

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV
por: De Nicolò, Amedeo, et al.
Publicado: (2020)

COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics
por: Cusato, Jessica, et al.
Publicado: (2023)

Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia
por: Trunfio, Mattia, et al.
Publicado: (2022)

Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma
por: De Nicolò, Amedeo, et al.
Publicado: (2021)

On the SARS-CoV-2 “Variolation Hypothesis”: No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases
por: Trunfio, Mattia, et al.
Publicado: (2021)

Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study
por: Lombardi, Francesca, et al.
Publicado: (2023)

Patterns of Cerebrospinal Fluid Alzheimer’s Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition
por: Trunfio, Mattia, et al.
Publicado: (2022)

Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz
por: Cusato, Jessica, et al.
Publicado: (2021)

The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries
por: Trunfio, Mattia, et al.
Publicado: (2021)

Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from “Integriamoci”, a Pilot Pharmacokinetic Study
por: Avataneo, Valeria, et al.
Publicado: (2022)

Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring
por: Cusato, Jessica, et al.
Publicado: (2021)

Efficacy of Dolutegravir versus Darunavir in Antiretroviral First-Line Regimens According to Resistance Mutations and Viral Subtype
por: Salvo, Pierluigi Francesco, et al.
Publicado: (2023)

Virological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but Possible
por: Pena, M J, et al.
Publicado: (2018)

Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice
por: Borghetti, Alberto, et al.
Publicado: (2021)

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
por: Prosperi, Mattia CF, et al.
Publicado: (2012)

Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases
por: Trunfio, Mattia, et al.
Publicado: (2022)

Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections
por: Stroffolini, Giacomo, et al.
Publicado: (2022)

SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV-infected patients
por: Siccardi, M, et al.
Publicado: (2010)

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants
por: Cusato, Jessica, et al.
Publicado: (2022)

Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients
por: Trunfio, Mattia, et al.
Publicado: (2021)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
por: Allegra, Sarah, et al.
Publicado: (2017)

Low cerebrospinal fluid Amyloid-βeta 1–42 in patients with tuberculous meningitis
por: Stroffolini, Giacomo, et al.
Publicado: (2021)

Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)
por: Ciccullo, Arturo, et al.
Publicado: (2019)

Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients
por: Cosma, Stefano, et al.
Publicado: (2021)

Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice
por: Borghetti, Alberto, et al.
Publicado: (2019)

Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation
por: Leger, Paul, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7em3ig4nfn4utflgqglpqms3va